GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Plans » CVS Health Corp (BSP:CVSH34) » Definitions » EV-to-EBITDA

CVS Health (BSP:CVSH34) EV-to-EBITDA

: 8.96 (As of Today)
View and export this data going back to . Start your Free Trial

EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, CVS Health's enterprise value is R$811,058 Mil. CVS Health's EBITDA for the trailing twelve months (TTM) ended in Dec. 2023 was R$90,529 Mil. Therefore, CVS Health's EV-to-EBITDA for today is 8.96.

The historical rank and industry rank for CVS Health's EV-to-EBITDA or its related term are showing as below:

BSP:CVSH34' s EV-to-EBITDA Range Over the Past 10 Years
Min: 7.25   Med: 10.66   Max: 21.53
Current: 8.56

During the past 13 years, the highest EV-to-EBITDA of CVS Health was 21.53. The lowest was 7.25. And the median was 10.66.

BSP:CVSH34's EV-to-EBITDA is ranked worse than
53.33% of 15 companies
in the Healthcare Plans industry
Industry Median: 8.56 vs BSP:CVSH34: 8.56

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

As of today (2024-04-23), CVS Health's stock price is R$36.20. CVS Health's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 was R$3.215. Therefore, CVS Health's PE Ratio for today is 11.26.

The "classic" EV-to-EBITDA is much better in capturing debt and net cash than the PE Ratio.


CVS Health EV-to-EBITDA Historical Data

The historical data trend for CVS Health's EV-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

CVS Health Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EV-to-EBITDA
Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 10.85 9.58 11.42 14.29 9.33

CVS Health Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
EV-to-EBITDA Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 14.29 12.64 14.34 8.36 9.33

Competitive Comparison

For the Healthcare Plans subindustry, CVS Health's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


CVS Health EV-to-EBITDA Distribution

For the Healthcare Plans industry and Healthcare sector, CVS Health's EV-to-EBITDA distribution charts can be found below:

* The bar in red indicates where CVS Health's EV-to-EBITDA falls into.



CVS Health EV-to-EBITDA Calculation

CVS Health's EV-to-EBITDA for today is calculated as:

EV-to-EBITDA=Enterprise Value (Today)/EBITDA (TTM)
=811058.017/90528.928
=8.96

CVS Health's current Enterprise Value is R$811,058 Mil.
CVS Health's EBITDA for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was R$90,529 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


CVS Health  (BSP:CVSH34) EV-to-EBITDA Explanation

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

CVS Health's PE Ratio for today is calculated as:

PE Ratio=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=36.20/3.215
=11.26

CVS Health's share price for today is R$36.20.
CVS Health's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was R$3.215.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio.

Please read Which price ratio outperforms the enterprise multiple?


CVS Health EV-to-EBITDA Related Terms

Thank you for viewing the detailed overview of CVS Health's EV-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.


CVS Health (BSP:CVSH34) Business Description

Address
One CVS Drive, Woonsocket, RI, USA, 02895
CVS Health offers a diverse set of healthcare services. Its roots are in its retail pharmacy operations, where it operates over 9,000 stores primarily in the U.S. CVS is also the largest pharmacy benefit manager (acquired through Caremark), processing over 2 billion adjusted claims annually. It also operates a top-tier health insurer (acquired through Aetna) where it serves about 26 million medical members. The company's recent acquisition of Oak Street adds primary care services to the mix, which could have significant synergies with all its existing business lines.

CVS Health (BSP:CVSH34) Headlines

No Headlines